Goldman Sachs Group INC Schedule 13G passive stakes

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a passive beneficial ownership of 5.7% in FACT II ACQUISITION CORP's Class A ordinary shares.

The Goldman Sachs Group, Inc. and its affiliate Goldman Sachs & Co. LLC have reported a 5.7% beneficial ownership stake in EHEALTH, INC., held for investment purposes.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a passive beneficial ownership of 7.7% in Definitive Healthcare Corp.'s common stock as of March 31, 2025.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a beneficial ownership of 6.8% in Cross Country Healthcare, Inc. common stock.

The Goldman Sachs Group, Inc. and its affiliate, Goldman Sachs & Co. LLC, have reported a 6.0% beneficial ownership stake in Chimerix, Inc. common stock through a Schedule 13G filing.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a passive beneficial ownership of 8.0% in AUDDIA INC's common stock.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have jointly disclosed a passive beneficial ownership of 5.2% in Astronics Corporation's common stock.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have jointly filed a Schedule 13G, reporting beneficial ownership of 5.0% of Accolade, Inc.'s Class A common stock as of March 31, 2025.

Goldman Sachs Group Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, disclosing a beneficial ownership of 1.0% in Winnebago Industries Inc. common stock as of April 30, 2025.

Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC filed an amended Schedule 13G, correcting their beneficial ownership in Inflection Point Acquisition Corp. Class A ordinary shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, disclosing a beneficial ownership of 2.4% in Weibo Corporation's American Depositary Shares as of December 31, 2024.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership of 5.4% in TC Energy Corporation as of December 31, 2024.

Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G indicating they no longer hold a beneficial ownership stake in Lumos Pharma, Inc. as of December 31, 2024.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have jointly disclosed a beneficial ownership of 7.3% in Andretti Acquisition Corp. II's Class A ordinary shares as of December 31, 2024.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership of 5.7% in Launch Two Acquisition Corp.'s Class A ordinary shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership of 6.9% in M3BRIGADE ACQUISITION V CORP.'s Class A ordinary shares as of December 31, 2024.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting a passive beneficial ownership of 0.0% in VIZIO Holding Corp.'s Class A common stock as of December 31, 2024.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a passive beneficial ownership of 7.0% in Syndax Pharmaceuticals, Inc. common stock as of December 31, 2024.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, confirming a passive beneficial ownership of 130 shares, representing 0.0% of Kiora Pharmaceuticals, Inc.'s common stock as of December 31, 2024.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership of 5.2% in HCM II Acquisition Corp's Class A Ordinary Shares as of December 31, 2024.

Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have reported a combined beneficial ownership of 7.7% in GRAF Global Corp.'s Class A ordinary shares as of December 31, 2024.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a beneficial ownership of 7.2% in GigCapital7 Corp.'s Class A ordinary shares as of December 31, 2024.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amendment to disclose a passive beneficial ownership of 3.3% in ZEO Energy Corp.'s Class A Common Stock as of December 31, 2024.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership of 7.2% in EQV Ventures Acquisition Corp.'s Class A Ordinary Shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a beneficial ownership of 6.8% in Cohen Circle Acquisition Corp. I, totaling 1,617,151 Class A ordinary shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting a passive beneficial ownership of 3.0% in Centurion Acquisition Corp.'s Class A ordinary shares as of December 31, 2024.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership of 6.5% of AMC Entertainment Holdings, Inc.'s Class A common stock as of December 31, 2024.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a passive beneficial ownership of 6.0% in WillScot Mobile Mini Holdings Corp., totaling over 11.1 million shares as of December 31, 2024.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership of 7.0% in Outfront Media Inc., totaling over 12.1 million shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have jointly disclosed a beneficial ownership of 7.6% in Martin Midstream Partners L.P. common stock as of December 31, 2024.